Soligenix, Inc.
NASDAQ: SNGX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher J. Schaber
- Employees
- 14
- Headquarters
- Princeton, United States
- IPO year
- 1994
- Market cap
- $4.0M
- Website
- https://www.soligenix.com
Loading SNGX…
Loading profile data…Frequently asked questions about SNGX
What does Soligenix, Inc. (SNGX) do?
Soligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions. Within the Specialized BioTher...
Where does SNGX trade?
Soligenix, Inc. (SNGX) trades on the NASDAQ Capital Market.
What sector is SNGX in?
Soligenix, Inc. (SNGX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Soligenix, Inc.?
Christopher J. Schaber is the chief executive officer of Soligenix, Inc. (SNGX).
Where is Soligenix, Inc. headquartered?
Soligenix, Inc. is headquartered in United States.
Does SNGX pay a dividend?
Soligenix, Inc. (SNGX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNGX go public?
Soligenix, Inc. (SNGX) completed its initial public offering in 1994.